Myotis brandtii (Brandt's bat): 102255250
Help
Entry
102255250 CDS
T02920
Symbol
MAPK3
Name
(RefSeq) mitogen-activated protein kinase 3
KO
K04371
mitogen-activated protein kinase 1/3 [EC:
2.7.11.24
]
Organism
myb
Myotis brandtii (Brandt's bat)
Pathway
myb01521
EGFR tyrosine kinase inhibitor resistance
myb01522
Endocrine resistance
myb01524
Platinum drug resistance
myb04010
MAPK signaling pathway
myb04012
ErbB signaling pathway
myb04014
Ras signaling pathway
myb04015
Rap1 signaling pathway
myb04022
cGMP-PKG signaling pathway
myb04024
cAMP signaling pathway
myb04062
Chemokine signaling pathway
myb04066
HIF-1 signaling pathway
myb04068
FoxO signaling pathway
myb04071
Sphingolipid signaling pathway
myb04072
Phospholipase D signaling pathway
myb04114
Oocyte meiosis
myb04140
Autophagy - animal
myb04148
Efferocytosis
myb04150
mTOR signaling pathway
myb04151
PI3K-Akt signaling pathway
myb04210
Apoptosis
myb04218
Cellular senescence
myb04261
Adrenergic signaling in cardiomyocytes
myb04270
Vascular smooth muscle contraction
myb04350
TGF-beta signaling pathway
myb04360
Axon guidance
myb04370
VEGF signaling pathway
myb04371
Apelin signaling pathway
myb04380
Osteoclast differentiation
myb04510
Focal adhesion
myb04520
Adherens junction
myb04540
Gap junction
myb04550
Signaling pathways regulating pluripotency of stem cells
myb04611
Platelet activation
myb04613
Neutrophil extracellular trap formation
myb04620
Toll-like receptor signaling pathway
myb04621
NOD-like receptor signaling pathway
myb04625
C-type lectin receptor signaling pathway
myb04650
Natural killer cell mediated cytotoxicity
myb04657
IL-17 signaling pathway
myb04658
Th1 and Th2 cell differentiation
myb04659
Th17 cell differentiation
myb04660
T cell receptor signaling pathway
myb04662
B cell receptor signaling pathway
myb04664
Fc epsilon RI signaling pathway
myb04666
Fc gamma R-mediated phagocytosis
myb04668
TNF signaling pathway
myb04713
Circadian entrainment
myb04720
Long-term potentiation
myb04722
Neurotrophin signaling pathway
myb04723
Retrograde endocannabinoid signaling
myb04724
Glutamatergic synapse
myb04725
Cholinergic synapse
myb04726
Serotonergic synapse
myb04730
Long-term depression
myb04810
Regulation of actin cytoskeleton
myb04910
Insulin signaling pathway
myb04912
GnRH signaling pathway
myb04914
Progesterone-mediated oocyte maturation
myb04915
Estrogen signaling pathway
myb04916
Melanogenesis
myb04917
Prolactin signaling pathway
myb04919
Thyroid hormone signaling pathway
myb04921
Oxytocin signaling pathway
myb04926
Relaxin signaling pathway
myb04928
Parathyroid hormone synthesis, secretion and action
myb04929
GnRH secretion
myb04930
Type II diabetes mellitus
myb04933
AGE-RAGE signaling pathway in diabetic complications
myb04934
Cushing syndrome
myb04935
Growth hormone synthesis, secretion and action
myb04960
Aldosterone-regulated sodium reabsorption
myb05010
Alzheimer disease
myb05020
Prion disease
myb05022
Pathways of neurodegeneration - multiple diseases
myb05034
Alcoholism
myb05132
Salmonella infection
myb05133
Pertussis
myb05135
Yersinia infection
myb05140
Leishmaniasis
myb05142
Chagas disease
myb05145
Toxoplasmosis
myb05152
Tuberculosis
myb05160
Hepatitis C
myb05161
Hepatitis B
myb05163
Human cytomegalovirus infection
myb05164
Influenza A
myb05165
Human papillomavirus infection
myb05166
Human T-cell leukemia virus 1 infection
myb05167
Kaposi sarcoma-associated herpesvirus infection
myb05170
Human immunodeficiency virus 1 infection
myb05171
Coronavirus disease - COVID-19
myb05200
Pathways in cancer
myb05203
Viral carcinogenesis
myb05205
Proteoglycans in cancer
myb05206
MicroRNAs in cancer
myb05207
Chemical carcinogenesis - receptor activation
myb05208
Chemical carcinogenesis - reactive oxygen species
myb05210
Colorectal cancer
myb05211
Renal cell carcinoma
myb05212
Pancreatic cancer
myb05213
Endometrial cancer
myb05214
Glioma
myb05215
Prostate cancer
myb05216
Thyroid cancer
myb05218
Melanoma
myb05219
Bladder cancer
myb05220
Chronic myeloid leukemia
myb05221
Acute myeloid leukemia
myb05223
Non-small cell lung cancer
myb05224
Breast cancer
myb05225
Hepatocellular carcinoma
myb05226
Gastric cancer
myb05230
Central carbon metabolism in cancer
myb05231
Choline metabolism in cancer
myb05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
myb05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
myb00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
102255250 (MAPK3)
04012 ErbB signaling pathway
102255250 (MAPK3)
04014 Ras signaling pathway
102255250 (MAPK3)
04015 Rap1 signaling pathway
102255250 (MAPK3)
04350 TGF-beta signaling pathway
102255250 (MAPK3)
04370 VEGF signaling pathway
102255250 (MAPK3)
04371 Apelin signaling pathway
102255250 (MAPK3)
04668 TNF signaling pathway
102255250 (MAPK3)
04066 HIF-1 signaling pathway
102255250 (MAPK3)
04068 FoxO signaling pathway
102255250 (MAPK3)
04072 Phospholipase D signaling pathway
102255250 (MAPK3)
04071 Sphingolipid signaling pathway
102255250 (MAPK3)
04024 cAMP signaling pathway
102255250 (MAPK3)
04022 cGMP-PKG signaling pathway
102255250 (MAPK3)
04151 PI3K-Akt signaling pathway
102255250 (MAPK3)
04150 mTOR signaling pathway
102255250 (MAPK3)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
102255250 (MAPK3)
04148 Efferocytosis
102255250 (MAPK3)
09143 Cell growth and death
04114 Oocyte meiosis
102255250 (MAPK3)
04210 Apoptosis
102255250 (MAPK3)
04218 Cellular senescence
102255250 (MAPK3)
09144 Cellular community - eukaryotes
04510 Focal adhesion
102255250 (MAPK3)
04520 Adherens junction
102255250 (MAPK3)
04540 Gap junction
102255250 (MAPK3)
04550 Signaling pathways regulating pluripotency of stem cells
102255250 (MAPK3)
09142 Cell motility
04810 Regulation of actin cytoskeleton
102255250 (MAPK3)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
102255250 (MAPK3)
04613 Neutrophil extracellular trap formation
102255250 (MAPK3)
04620 Toll-like receptor signaling pathway
102255250 (MAPK3)
04621 NOD-like receptor signaling pathway
102255250 (MAPK3)
04625 C-type lectin receptor signaling pathway
102255250 (MAPK3)
04650 Natural killer cell mediated cytotoxicity
102255250 (MAPK3)
04660 T cell receptor signaling pathway
102255250 (MAPK3)
04658 Th1 and Th2 cell differentiation
102255250 (MAPK3)
04659 Th17 cell differentiation
102255250 (MAPK3)
04657 IL-17 signaling pathway
102255250 (MAPK3)
04662 B cell receptor signaling pathway
102255250 (MAPK3)
04664 Fc epsilon RI signaling pathway
102255250 (MAPK3)
04666 Fc gamma R-mediated phagocytosis
102255250 (MAPK3)
04062 Chemokine signaling pathway
102255250 (MAPK3)
09152 Endocrine system
04910 Insulin signaling pathway
102255250 (MAPK3)
04929 GnRH secretion
102255250 (MAPK3)
04912 GnRH signaling pathway
102255250 (MAPK3)
04915 Estrogen signaling pathway
102255250 (MAPK3)
04914 Progesterone-mediated oocyte maturation
102255250 (MAPK3)
04917 Prolactin signaling pathway
102255250 (MAPK3)
04921 Oxytocin signaling pathway
102255250 (MAPK3)
04926 Relaxin signaling pathway
102255250 (MAPK3)
04935 Growth hormone synthesis, secretion and action
102255250 (MAPK3)
04919 Thyroid hormone signaling pathway
102255250 (MAPK3)
04928 Parathyroid hormone synthesis, secretion and action
102255250 (MAPK3)
04916 Melanogenesis
102255250 (MAPK3)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
102255250 (MAPK3)
04270 Vascular smooth muscle contraction
102255250 (MAPK3)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
102255250 (MAPK3)
09156 Nervous system
04724 Glutamatergic synapse
102255250 (MAPK3)
04725 Cholinergic synapse
102255250 (MAPK3)
04726 Serotonergic synapse
102255250 (MAPK3)
04720 Long-term potentiation
102255250 (MAPK3)
04730 Long-term depression
102255250 (MAPK3)
04723 Retrograde endocannabinoid signaling
102255250 (MAPK3)
04722 Neurotrophin signaling pathway
102255250 (MAPK3)
09158 Development and regeneration
04360 Axon guidance
102255250 (MAPK3)
04380 Osteoclast differentiation
102255250 (MAPK3)
09159 Environmental adaptation
04713 Circadian entrainment
102255250 (MAPK3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
102255250 (MAPK3)
05206 MicroRNAs in cancer
102255250 (MAPK3)
05205 Proteoglycans in cancer
102255250 (MAPK3)
05207 Chemical carcinogenesis - receptor activation
102255250 (MAPK3)
05208 Chemical carcinogenesis - reactive oxygen species
102255250 (MAPK3)
05203 Viral carcinogenesis
102255250 (MAPK3)
05230 Central carbon metabolism in cancer
102255250 (MAPK3)
05231 Choline metabolism in cancer
102255250 (MAPK3)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
102255250 (MAPK3)
09162 Cancer: specific types
05210 Colorectal cancer
102255250 (MAPK3)
05212 Pancreatic cancer
102255250 (MAPK3)
05225 Hepatocellular carcinoma
102255250 (MAPK3)
05226 Gastric cancer
102255250 (MAPK3)
05214 Glioma
102255250 (MAPK3)
05216 Thyroid cancer
102255250 (MAPK3)
05221 Acute myeloid leukemia
102255250 (MAPK3)
05220 Chronic myeloid leukemia
102255250 (MAPK3)
05218 Melanoma
102255250 (MAPK3)
05211 Renal cell carcinoma
102255250 (MAPK3)
05219 Bladder cancer
102255250 (MAPK3)
05215 Prostate cancer
102255250 (MAPK3)
05213 Endometrial cancer
102255250 (MAPK3)
05224 Breast cancer
102255250 (MAPK3)
05223 Non-small cell lung cancer
102255250 (MAPK3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
102255250 (MAPK3)
05170 Human immunodeficiency virus 1 infection
102255250 (MAPK3)
05161 Hepatitis B
102255250 (MAPK3)
05160 Hepatitis C
102255250 (MAPK3)
05171 Coronavirus disease - COVID-19
102255250 (MAPK3)
05164 Influenza A
102255250 (MAPK3)
05163 Human cytomegalovirus infection
102255250 (MAPK3)
05167 Kaposi sarcoma-associated herpesvirus infection
102255250 (MAPK3)
05165 Human papillomavirus infection
102255250 (MAPK3)
09171 Infectious disease: bacterial
05132 Salmonella infection
102255250 (MAPK3)
05135 Yersinia infection
102255250 (MAPK3)
05133 Pertussis
102255250 (MAPK3)
05152 Tuberculosis
102255250 (MAPK3)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
102255250 (MAPK3)
05140 Leishmaniasis
102255250 (MAPK3)
05142 Chagas disease
102255250 (MAPK3)
09164 Neurodegenerative disease
05010 Alzheimer disease
102255250 (MAPK3)
05020 Prion disease
102255250 (MAPK3)
05022 Pathways of neurodegeneration - multiple diseases
102255250 (MAPK3)
09165 Substance dependence
05034 Alcoholism
102255250 (MAPK3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
102255250 (MAPK3)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
102255250 (MAPK3)
04933 AGE-RAGE signaling pathway in diabetic complications
102255250 (MAPK3)
04934 Cushing syndrome
102255250 (MAPK3)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
102255250 (MAPK3)
01524 Platinum drug resistance
102255250 (MAPK3)
01522 Endocrine resistance
102255250 (MAPK3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
myb01001
]
102255250 (MAPK3)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:
myb03036
]
102255250 (MAPK3)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:
myb04147
]
102255250 (MAPK3)
Enzymes [BR:
myb01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
102255250 (MAPK3)
Protein kinases [BR:
myb01001
]
Serine/threonine kinases: CMGC group
MAPK family [OT]
102255250 (MAPK3)
Chromosome and associated proteins [BR:
myb03036
]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
102255250 (MAPK3)
Exosome [BR:
myb04147
]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
102255250 (MAPK3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
ABC1
APH
Haspin_kinase
Kdo
FTA2
Motif
Other DBs
NCBI-GeneID:
102255250
NCBI-ProteinID:
XP_005882041
UniProt:
S7NJF5
LinkDB
All DBs
Position
Un
AA seq
467 aa
AA seq
DB search
MGNSSAALTALPASCLPPAPVTPSFSRYLPHCLPCTRLPAPDLSRLREPIAGRGRAARRE
RAAERGSLSGRSSSLCEVTEGLPGRSPAFSLESAGLRSRKEPALFTTWPEPTRLPPFPAT
AWVGPAGLDSPYVGPHQHHLSGPLSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQIL
LRFRHENVISIRDILRAPTLDAMRDVYIVQDLMETDLYKLLKSQQLSNDHVCYFLYQILR
GLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA
PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI
INMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ
YYDPTDEPVAEEPFTFDMELDDLPKERLKELIFQETARFQPGVLEAT
NT seq
1404 nt
NT seq
+upstream
nt +downstream
nt
atggggaacagctctgctgccctgacagccctgcctgcctcatgcctccctccagccccc
gtgactccctccttctcccggtatttgcctcactgtctgccctgcactcgtctcccagcc
cccgacctgtccaggctgcgggagcccatcgcggggcggggcagggcagctcgaagggag
cgggctgcagagaggggaagtctgagcggccgctcttcctctctttgtgaagtcaccgaa
gggctgcctggccggtccccagctttctccctggagagcgcaggccttcgcagcaggaag
gaaccagcattgtttacgacttggccagagcccactcggctccctcccttcccggccacg
gcctgggtggggccagctggcctggactccccctatgtaggaccacaccaacaccacctc
tctggccctctcagctcagcttacgaccacgtccgcaagacacgcgtggccatcaagaaa
atcagccccttcgagcaccagacctactgccagcgcacgctgcgggaaatccagatcttg
ctgcgcttccgccacgagaatgtcatcagcatccgagacattcttcgggcacctaccctg
gatgccatgagggatgtctacattgtgcaggacctgatggagacagacctgtacaagttg
ctcaaaagccagcagctgagcaacgaccacgtctgctacttcctctaccagatcctgcgg
ggcctcaagtatatccactcagctaacgtgctccaccgggatttaaagccctccaacctg
ctcatcaacaccacctgcgaccttaagatctgcgattttggcctggcccggatcgccgat
cccgagcatgaccacacgggcttcctgacagaatacgtggccacgcgctggtaccgggcc
ccagagatcatgctgaactccaagggctacaccaagtccatcgatatctggtctgtgggc
tgcattctggctgaaatgctctccaaccggcccatcttccctggcaagcactacctggac
cagctcaaccacattctgggcatcctgggttccccatcccaagaggacctgaattgtatc
atcaacatgaaggcccggaactacctgcagtctctgccttccaagaccaaggtggcctgg
gccaagctcttccccaagtcagactccaaagcccttgacctgctggaccggatgttgacc
tttaaccctaataaacggatcacagtagaagaagccctggctcacccctacctggagcag
tactacgacccaacagatgagccagtggccgaggaacctttcacctttgacatggagctg
gatgatctacccaaggagcggctgaaggagctcatattccaggagacagcccgcttccag
cctggggtgctggaggccacctaa
DBGET
integrated database retrieval system